文献速递乳房整形与再造显微修复重建

去甲肾上腺素与去氧肾上腺素在游离腹直肌皮瓣乳房再造术中维持皮瓣血流的比较:一项随机先导研究

Norepinephrine preserved flap blood flow compared to phenylephrine in free transverse rectus abdominis myocutaneous flap breast reconstruction surgery: A randomized pilot study.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2023-05-04

该随机先导研究纳入20例游离腹直肌皮瓣乳房再造患者,每组10例,分别泵入去甲肾上腺素(0.03-0.10 µg/kg/min)或去氧肾上腺素(0.42-1.25 µg/kg/min)维持平均动脉压65-80 mmHg。吻合后去甲肾上腺素组皮瓣平均血流量无显著变化,而去氧肾上腺素组平均血流量降低;两组搏动指数均无变化,次要结局无差异。作者认为去甲肾上腺素似乎较去氧肾上腺素更好地维持皮瓣灌注,但需进一步验证研究。

要点

  • 去甲肾上腺素组吻合后皮瓣平均血流量无显著变化(平均差-9.4 ± 14.2 mL/min,p=0.082)。
  • 去氧肾上腺素组吻合后皮瓣平均血流量降低(-7.9 ± 8.2 mL/min,p=0.021)。
  • 两组搏动指数及皮瓣丢失、坏死、血栓、伤口感染、7天内再手术等次要结局无差异。

核心结论

  • 在游离腹直肌皮瓣乳房再造术中,去甲肾上腺素似乎较去氧肾上腺素更好地维持皮瓣灌注,但需进一步验证研究。

研究设计与样本

  • 随机先导研究,纳入行游离腹直肌皮瓣乳房再造的患者20例,随机分为去甲肾上腺素组(n=10)和去氧肾上腺素组(n=10)。
  • 排除外周动脉疾病、研究药物过敏、既往腹部手术、左心室功能障碍或未控制心律失常的患者。
  • 去甲肾上腺素剂量0.03-0.10 µg/kg/min,去氧肾上腺素剂量0.42-1.25 µg/kg/min,维持平均动脉压65-80 mmHg。
  • 主要结局为吻合后使用传输时间血流仪测量的皮瓣血管平均血流量和搏动指数;次要结局包括术后7天内皮瓣丢失、坏死、血栓、伤口感染和再手术。

主要发现

  • 吻合后去甲肾上腺素组平均血流量无显著变化(平均差-9.4 ± 14.2 mL/min,p=0.082)。
  • 吻合后去氧肾上腺素组平均血流量降低(-7.9 ± 8.2 mL/min,p=0.021)。
  • 搏动指数在去甲肾上腺素组(0.4 ± 1.0,p=0.285)和去氧肾上腺素组(1.3 ± 3.1,p=0.252)均无变化。
  • 两组次要结局无差异。

局限性

  • 原文结论指出需进一步验证研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vasopressors are used in up to 85% of cases during free flap surgery. However, their use is still debated with concerns of vasoconstriction-related complications, with rates up to 53% in minor cases. We investigated the effects of vasopressors on flap blood flow during free flap breast reconstruction surgery. We hypothesized that norepinephrine may preserve flap perfusion better than phenylephrine during free flap transfer. METHODS: A randomized pilot study was performed in patients undergoing free transverse rectus abdominis myocutaneous (TRAM) flap breast reconstruction. Patients with peripheral artery disease, allergies to study drugs, previous abdominal operations, left ventricular dysfunction, or uncontrolled arrhythmias were excluded. Twenty patients were randomized to receive either norepinephrine (0.03-0.10 µg/kg/min) or phenylephrine (0.42-1.25 µg/kg/min) (each n = 10) to maintain a mean arterial pressure of 65-80 mmHg. The primary outcome was differences in mean blood flow (MBF) and pulsatility index (PI) of flap vessels after anastomosis measured using transit time flowmetry in the two groups. Secondary outcomes included flap loss, necrosis, thrombosis, wound infection, and reoperation within 7 days postoperatively. RESULTS: After anastomosis, MBF showed no significant change in the norepinephrine group (mean difference, -9.4 ± 14.2 mL/min; p = 0.082), whereas it was reduced in the phenylephrine group (-7.9 ± 8.2 mL/min; p = 0.021). PI did not change in either group (0.4 ± 1.0 and 1.3 ± 3.1 in the norepinephrine and phenylephrine groups; p = 0.285 and 0.252, respectively). There were no differences in secondary outcomes between the groups. CONCLUSION: During free TRAM flap breast reconstruction, norepinephrine seems to preserve flap perfusion compared to phenylephrine. However, further validation studies are required.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Lee S, Ju JW, Yoon S, et al. Norepinephrine preserved flap blood flow compared to phenylephrine in free transverse rectus abdominis myocutaneous flap breast reconstruction surgery: A randomized pilot study. J Plast Reconstr Aesthet Surg. 2023. PMID: 37311286. doi:10.1016/j.bjps.2023.04.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。